Biomarin
BioMarin develops and commercialises innovative biopharmaceuticals for rare diseases driven by genetic causes.
Financial Data
-
31st Dec 19 Source: CRO
- €1 billion turnover
-
€42 million
profit - 434 employees
-
31st Dec 18 Source: CRO
- €1.1 billion turnover
-
€43 million
profit - 385 employees
- 4 more years available »
Ranking
By Turnover
(€1 billion)- 95th in Top Companies
- 15th in Health
By Employees
(434)- 412th in Top Companies
- 61st in Health
- 434
- €1 billion
Employees
- Michael O’Donnell CEO/Managing Director
Latest News
- 5:00am Davy locks local rival Cantor Fitzgerald out of sale process
- 4:58am OECD tax chief says Ireland will need to decide on sensitive issue of 12.5% tax rate
- Apr 16 Aer Lingus faces further cost cuts if summer revenues are lost, chief says
- Apr 16 Carphone Warehouse considers closing its stores in Ireland
- Apr 16 European stocks notch new highs as Daimler earnings lift car makers